Rasmussen M H, Jensen L T, Andersen T, Breum L, Hilsted J
Department of Endocrinology, Hvidovre Hospital, University of Copenhagen, Denmark.
Int J Obes Relat Metab Disord. 1995 Sep;19(9):659-63.
To investigate the impact of obesity, fat distribution and weight loss on collagen turnover using serum concentrations of the carboxyterminal propeptide of type I procollagen (S-PICP) and the aminoterminal propeptide of type III pro-collagen (S-PIIINP) as markers for collagen turnover.
Blood samples were obtained once at baseline, and after 8 and 16 weeks of dietary treatment (5.0 MJ/day diet).
Outpatient clinic of Hvidovre University Hospital.
S-PICP, S-PIIINP, fat distribution and weight loss.
S-PIIINP was associated with body weight (r = 0.37; P = 0.004), height (r = 0.27; P = 0.04), waist circumference (r = 0.35; P = 0.007), as well as with WHR (r = 0.33; P = 0.01) and was inversely correlated to age (r = -0.40; P = 0.002). Compared with randomly selected controls from a large pool of healthy volunteers, the obese patients had elevated S-PIIINP values before as well as during weight loss, whereas S-PICP levels were within the normal range and did not correlate with any anthropometric measures. The average weight loss after 16 weeks dietary treatment was 8.1 kg (s.d. = 0.8). S-PIIINP decreased during the 16 weeks of energy restriction (P < 0.05) and changes in S-PIIINP was correlated to body weight loss (r = 0.32; P < 0.05) and to changes in waist circumference (r = 0.34; P < 0.05) as well as changes in WHR (r = 0.30; P < 0.05).
S-PIIINP is elevated in obesity and associated with body fat distribution, suggesting an increased turnover of type III collagen related to obesity in general and to abdominal obesity in particular. S-PIIINP levels decreases during weight loss in obese subjects, whereas S-PICP levels seems un-related to obesity and weight loss.
以血清I型前胶原羧基末端前肽(S-PICP)和III型前胶原氨基末端前肽(S-PIIINP)浓度作为胶原转换的标志物,研究肥胖、脂肪分布及体重减轻对胶原转换的影响。
在基线时、饮食治疗8周和16周后(5.0兆焦耳/天的饮食)采集血样。
维德夫勒大学医院门诊。
S-PICP、S-PIIINP、脂肪分布和体重减轻。
S-PIIINP与体重(r = 0.37;P = 0.004)、身高(r = 0.27;P = 0.04)、腰围(r = 0.35;P = 0.007)以及腰臀比(WHR,r = 0.33;P = 0.01)相关,且与年龄呈负相关(r = -0.40;P = 0.002)。与从大量健康志愿者中随机选取的对照组相比,肥胖患者在减肥前及减肥期间的S-PIIINP值均升高,而S-PICP水平在正常范围内,且与任何人体测量指标均无相关性。16周饮食治疗后的平均体重减轻为8.1千克(标准差 = 0.8)。在16周的能量限制期间,S-PIIINP降低(P < 0.05),S-PIIINP的变化与体重减轻相关(r = 0.32;P < 0.05),与腰围变化相关(r = 0.34;P < 0.05),也与WHR变化相关(r = 0.30;P < 0.05)。
肥胖患者的S-PIIINP升高,且与体脂分布相关,提示III型胶原转换增加与一般肥胖尤其是腹部肥胖有关。肥胖受试者减肥期间S-PIIINP水平降低,而S-PICP水平似乎与肥胖和体重减轻无关。